Purine ring-opened 7-methylguanine, prepared in vitro by alkaline treatment of 7-methylguanosine or of methylated calf thymus DNA, was extensively characterized by chromatographk and spectral techniques as N'-methyi-N'-fonnyl-2,5,6-triamlno-4-hydroxypyrimidine. This modified base chromatographed as an early-eluting peak on an ionexchange column but separated into two interconvertible components after reversed-phase or porous-resin h.p.l.c. The two components were analyzed by thermal desorption mass spectrometry and 500 MHz 'H-n.m.r. spectroscopy. Thdr mass spectra were identical (M + at m/z 183) and their n.m.r. spectra each exhibited the same two sets of resonances whose relative intensities were solvent-dependent. Analysis by h.p.l.c. showed interconversion of the two components and kinetic studies demonstrated that this reaction was a reversible first-order process. At equilibrium, k l = k 2 = 0.334 h " ] and AG* = 22.9 kcal/mol. These data indicated that the ring-opened 7-methylguanine exists as cis/trans isomers with restricted rotation about the amide bond. Treatment of rats with an intraurethral initiating dose of the carcinogen N-methylnitrosourea resulted in a high level of bladder epithelial DNA modification with 7-methylguanine, O 6 -methylguanine, and methyl phosphotriesters as major adducts at 2 h after instillation. Purine ring-opened 7-methylguanine, chromatographically identical to the in vitro products, was initially a minor adduct. However, it was the only persistent modification in the bladder epithelial DNA and eventually accounted for 72% of the total carcinogen binding after 21 days. A tumor-promoting regimen, involving dietary sodium saccharin, did not alter the repair or persistence of any of the methylated adducts. These data demonstrate that purine ring-opened 7-methylguanine, previously reported to exist in liver DNA after N,N-dimethylnitrosamine or 1,2-dimethylhydrazine treatment, is present in a carcinogen-target tissue and is considerably more persistent than O 6 -methylguanine or other DNA methylation products. The possible role of this adduct as a promutagenic lesion initiating urinary bladder cardnogenesis is discussed.
Introduction
Carcinogenic and mutagenic alkylating agents such as nitrosamides and nitrosamines are generally considered to exert
•Abbreviations: 7-Me-G, 7-methylguanine; r.o. 7-Me-G, 8,9-purine ringopened 7-Me-G; O*-Me-G, O'-methylguanine; 3-Me-G, 3-methylguanine; 1-Me-A, 1-methyladenine; 3-Me-A, 3-methyladenine; O-Me-T, OMnethylthymidine; TpMeT, methyl phosphotriester of thymidylyl{3'-5')thymidine; MNU, N-methylnitrosourea. their biological activities through modification of cellular DNA (1 -4) . For methylating agents, the major DNA adduct formed in vitro or in vivo is 7-methylguanine (7-Me-G)*. Minor alkylation products involve methylation at oxygen and nitrogen atoms in DNA bases as well as formation of methyl phosphotriesters (1, 3) . Numerous studies on the formation and persistence of specific methylated adducts in carcinogen target and non-target tissues of several species have strongly implicated O 6 -alkylation of guanine as a critical event for the initiation of tumorigenesis (reviewed in reference 4). More recently, however, there have been several reports in which the persistence of O 6 -alkylguanine did not correlate with carcinogenesis and it was suggested that DNA replication and repair processes or other methylated adducts may be important in this regard (e.g., 5 -12) .
In a preliminary study, we detected a major carcinogen-DNA adduct in the livers of rats after treatment with N,N-dimethylnitrosamine or 1,2-dimethylhydrazine and identified it as an 8,9-purine ring-opened derivative of 7-Me-G (r.o. 7-Me-G) by chromatographic, spectral, and enzymatic criteria (13) . This product has also been described by others as an in vitro product obtained by alkaline treatment of alkylated nucleosides or nucleic acids (14) (15) (16) (17) (18) (19) (20) (21) (22) . Glycosylases catalyzing the specific removal of r.o. 7-Me-G from DNA have also been reported (19, 23, 24) . In this study, we have established the structure of the r.o. 7-Me-G as cis and trans isomers of N 5 -methyl-N 5 -fonnyl-2,5,6-triamino-4-hydroxypyrirnidine and have examined the relative in vivo persistence of this adduct in the rat bladder after treatment with a tumor initiating dose of N-methylnitrosourea (MNU). [An intraurethral dose of 0.5 mg MNU was found to serve as an initiating dose in rats receiving a saccharin promoting regimen up to 24 months. The bladder tumor incidences in MNU-treated rats receiving 0, 0.5, 1.0, 2.5 and 5% dietary saccharin were 3, 15, 17, 37 and 3%, respectively, with the latter group exceeding the maximum tolerated dose of saccharin. The tumor incidences and dose-response relationships were highly significant (p <0.0001). A preliminary account of these results appeared in Proc. 2nd Natl. Bladder Cancer Conference: A17 (1983) .] The effects of a bladder tumor promoter, sodium saccharin (25, 26) , on the persistence and removal of methylated DNA adducts was also determined.
Materials and methods
Materials 7-Methylguanosine, calf thymus DNA (type I) and Sephadex G-10 were obtained from the Sigma Chemical Co. 2,5,6-Triamino-4-hydroxypyrimidine hemisulfate was purchased from Vega Biochemicals and deuterated solvents were obtained from Merck and Co. [CH ? -
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ed below. Purification of samples for spectral analyses was achieved with the porous-resin h.p.l.c. system. Preparation of calf thymus DNA containing r.o. 7-Me-G was carried out by alkaline dialysis of methylated DNA and subsequent reannealing in buffered saline as previously described (23) except that the DNA (15 mg) had been methylated with 8 /imol of pHJMNU (50 mCi/mmol) instead of dimethylsulfate. The methylated DNA contained 13.4 nrnol of methylated adducts per mg DNA.
Animals studies
Female NCTR:S11(SD) Sprague-Dawley rats, weighing 160-200 g, were each administered 0.5 mg of [ 3 H]MNU (90 or 107 mCi/mmol) in 0.2 ml of sterile saline by urethral catheter using techniques previously reported (27) . Groups of 30 -50 rats were sacrificed after 2 h, 2 days, 9 days, and 21 days. Other groups also received sodium saccharin at levels of 0.5, 2.5 or 5% in the diet, beginning 2 days after MNU instillation and continuing until the rats were sacrificed at 9 days. The basic diet was Purina 5010M. At each sacrifice, the bladders were removed and the epithelial DNA was isolated and purified (<0.1% RNA contamination) as reported earlier (27, 28) .
Analytical methods H.p.l.c. was carried out with two Altex model 110A pumps, an Altex model 420 microprocessor, a Rheodyne 7120 injector, a Waters Model 440 detector, and a Hewlett-Packard Model 338OA integrating recorder. Three h.p.l.c. systems were used: ion-exchange, on a Partisil-10 SCX/M9 cation exchange column (13, 29) ; reversed-phase, on a Waters analytical ^Bondapak C18 Semiprep column (13, 21) ; and porous-resin, on a Hamilton PRP-1 preparative column (13) .
Electron impact mass spectra were obtained with a Finnigan 4023 spectrometer equipped with a Vacumetric DCI thermal desorption probe. U.v. spectra were recorded with a Beckman 25 spectrophotometer. 'H-n.m.r. spectra were obtained with a Bruker WM500 spectrometer.
Methylated DNA adducts were quantified by h.p.l.c. after thermal, acidic and enzymatic hydrolysis as previously described (13, 29) except for r.o. 7-Me-G which required re-chromatography on the reversed-phase h.p.l.c. system (13) .
Results

Characterization of purine ring-opened 7-ntethylguanine as bP-methyl-hP-formyl-2,5,6-triamino-4-hydroxypyrimidine
Previous studies have presented evidence that alkaline treatment of methylated nucleic acids (15, 16, 18, 19) or of 7-alkylguanosines (14, 17, (20) (21) (22) results in a hydrolytic cleavage of the modified purine ring. After subsequent acid treatment to remove the sugar moiety, analysis of the modified bases by t.l.c, column chromatography, and h.p.l.c. showed the presence of two major products (16, 17, 21, 22 ) that were readily interconvertible. From chemical and spectral studies (14, 22) , it was suggested that these products were 8,9-ringopened derivatives. However, with our identification of this adduct in vivo (13), we felt that unambiguous structural characterization was essential. In this study, both 7-rnethylguanosine and MNU-treated calf thymus DNA were subjected to alkaline treatment as described by Chetsanga et al. (23) . The major alkylated ring-opened guanine products were isolated and characterized by thermal desorption mass spectrometry and 500-MHz 'H-n.m.r. spectroscopy; and their rates of interconversion were determined by h.p.l.c.
The r.o. 7-Me-G, prepared from 7-methylguanosine by alkali-treatment and subsequent acid hydrolysis, was purified by Sephadex G-10 column chromatography (23) . Analysis of the major column fraction by ion-exchange h.p.l.c. showed an early eluting peak at 3.5 min (cf. Figure 1A show re-chromatography of fraction b at 2 h and fraction c at 1 h, after separation, respectively. Fractions a, b and c were again re-chromatographed on the porous-resin column, the solvent was removed under reduced pressure, and the residues were analyzed by mass spectrometry. The mass spectrum of fractions b and c were identical and showed a M + at m/z 183. This result has been previously reported (13, 22) for r.o. 7-Me-G; however, comparison of relative ion intensities with total ion current indicated that the peaks at m/z 155 (M-CO) and 140 (M-CO-CHj) were fragments rather than a mixture of formylated/deformylated derivatives (22) . Analysis of component a, which also forms upon storage of components b and c, yielded an apparent M + at m/z 406 with major fragments at m/z 391 (M-CH3), 197, 181 and 165. These data suggested that component a was a polymeric oxidation product of r.o. 7-Me-G (components b and c) and may be the deformylated product previously described (22) . The 500-MHz 'H-n.m.r. spectrum of fractions b and c were also identical, both exhibiting two distinct sets of resonances ( Figure 3 ). These data suggested that the two h.p.l.c. components had undergone interconversion and that the doubled resonances each corresponded to two different forms of N'-methyl-N 5 -formyl-2,5,6-triamino-4-hydroxypyrimidine. The relative intensities of these resonances were solvent-dependent, being 1:9, 1:4, and 1:2 in dimethylsulfoxide-d 6 , methanol-d 4 , and dimethylsulfoxide-dj/D( 1/1), respectively. Analysis of r.o. 7-Me-G in these solvents by porous-resin h.p.l.c. confirmed these ratios and permitted assignment of n.m.r. spectral parameters to the h.p.l.c. components b and c, respectively (cf. legends to Figure 3 calculated to be 22.9 ± 0.3 kcal/mol. These data are uniquely consistent with the existence of two slowly interconvertible forms of N 5 -methyl-N 5 -formyl-2,5,6-triamino-4-hydroxypyrimidine, which can be attributed to partial double bond character about the amide bond resulting in cis/trans isomerism ( Figure 5 ). Component b was assigned as the cis conformer on the basis of a 7% nuclear Overhauser effect on the formyl proton caused by saturation of the methyl resonance at 2.93 p.p.m. No such effect was detected for component c by saturation of the methyl resonance at 2.80 p.p.m., indicating its identity as the trans conformer.
[The cis conformation is arbitrarily defined as the structure where the amide oxygen is cis to the pyrimidine ring.] Construction of CPK molecular models of cis and trans conformers also indicate the likelihood of steric hindrance between the methylformamido group and the exocyclic atoms of the pyrimidine ring. Thus, the minimum energy conformation is suggested to exist with the amido group orthogonal to the ring. The cis/trans conformers of formamides have previously been detected by n.m.r. spectroscopy and their relative proportions are known to be solvent-dependent (30) .
The identity of the r.o. 7-Me-G derived from 7-methylguanosine with that isolated from alkali-treated methylated calf thymus DNA was established by chromatographic and spectral comparisons. The methylated DNA, after extensive dialysis and reannealing (23) , was subjected to sequential thermal and acid hydrolyses (29) . Analyses by ion-exchange, reversed-phase, and porous-resin h.p.l.c. showed that the r.o. 7-Me-G accounted for 52% of the total methylated DNA adducts (cf. references 23, 29) . Of the total r.o. 7-Me-G, 40-50% was released by thermal hydrolysis and the remain- ing 50-60% recovered after the subsequent acid treatment. The r.o. 7-Me-G isolated from the alkali-treated methylated DNA also exhibited u.v. (14) and mass spectra that were identical to the product derived from alkali-treatment of 7-methylguanosine.
Control samples of purified methylated DNA which had not received alkali-treatment were also hydrolyzed and analyzed by h.p.l.c. Small, but detectable, amounts of r.o. 7-Me-G were found, accounting for 0.4% of the total methylated products.
Persistence of r.o. 7-Me-G in rat urothelial DNA after treatment with MNU or MNU and sodium saccharin
In our earlier report (13), we detected r.o. 7-Me-G as a major adduct in liver DNA after a single dose of N,N-dimethylnitrosamine or 1,2-dimethylhydrazine. However, since a single treatment with these methylating carcinogens does not induce liver tumors, we sought to examine the relative levels of r.o. 7-Me-G and its persistence in DNA of a carcinogentarget tissue. For this purpose, [*H]MNU was administered by urethral catheter to female Sprague-Dawley rats and groups were sacrificed after 2 h, 2 days, 9 days, or 21 days. Bladder epithelial DNA was isolated, hydrolyzed by thermal, acidic and enzymatic procedures and then analyzed by h.p.l.c. for all 16 possible base methylation products as well as for a representative methyl phosphotriester (TpMeT). As summarized in Table I , high levels of DNA alkylation were observed. 7-Me-G was initially the major adduct, but rapidly decreased (>99%) in the days following MNU instillation. By day 21, 7-Me-G accounted for only 7% of the total methylated products. As previously reported (27) , O 6 -Me-G was relatively more persistent, with O 6 -Me-G/7-Me-G ratios increasing from 0.11 to 1.3 during the sacrifice intervals. However, after 21 days, O 6 -Me-G represented only 10% of the total adducts. The minor products, 3-Me-G, 1-Me-A, 3-Me-A, and O*-Me-T were detectable at 2 h but disappeared within 2-9 days after MNU dosing. The representative phosphotriester, TpMeT, was observed throughout the experiment but at a low and continually decreasing level. In contrast, r.o. 7-Me-G appeared to be persistent over the time period studied and was the major adduct (7297o of the total binding) in the DNA by day 21.
The identity of the in vivo ring-opened adduct was confirmed by showing co-chromatography with the synthetic r.o. 7-Me-G on both ion-exchange and reversed-phase h.p.l.c. Furthermore, the artifactual formation of r.o. 7-Me-G from 7-Me-G was excluded by our failure to detect appreciable amounts (<1%) of r.o. 7-Me-G in DNA which had been methylated in vitro with MNU and then subjected to the same isolation and hydrolysis procedures used for the in vivo samples. It should also be noted that the r.o. 7-Me-G remained in the urothelial DNA at comparable levels throughout the study while 7-Me-G had essentially disappeared. In our previous report (13), we further demonstrated the presence of r.o. 7-Me-G in in vivo methylated DNA by showing that the intact DNA served as a substrate for a specific glycosylase that recognizes 8,9-purine ring-opened adducts.
Since saccharin has been shown to enhance bladder tumor formation after a low dose of MNU (25), we examined the possibility that saccharin's mechanism of action might involve alterations in the persistence or repair of methylated DNA adducts. In these experiments, additional groups of rats were given sodium saccharin in the diet beginning at 2 days after MNU treatment and were sacrificed after 9 days. The results, summarized in Table I , indicate that there is no appreciable or dose-related change in the repair of any of the methylated adducts. Thus, it would appear that saccharin as a tumor promoter has no effect on DNA repair events involved in tumor initiation.
Discussion
The identification of a carcinogen-modified ring-opened guanine derivative as a major and persistent lesion in bladder epithelial DNA is consistent with a growing body of evidence that such adducts could play an important role in the initiation of the neoplastic process. Hems (31) first suggested that this type of DNA modification could be important in radiation carcinogenesis since N 5 -formyl-2,5,6-triamino-4-hydroxypyrimidine was formed as a major product after treatment of guanosine with ionizing radiation. For chemical carcinogens, 8,9-guanine ring-opened derivatives of aflatoxin Bj have been identified; and their relative persistence in hepatic DNA has been proposed to play a critical role in aflatoxin-induced liver carcinogenesis (32 -34) . Similarly, the urinary bladder carcinogen, 2-naphthylamine, has been shown to yield an arylamine-substituted C8-guanine derivative which spontaneously hydrolyzes to an 8,9-ringopened product (35, 36) . This adduct appears to be persistent in the urothelium but not the liver of dogs given 2-naphthylamine (36) . Other aromatic amines such as 2-aminofluorene (37,38) and 4-aminobiphenyl (39) have also been reported to form C8-substituted purine-ring-opened derivatives in vivo; however, their biological importance has not yet been studied. Recently, purine ring-opened adducts have been detected in vitro after treatment of nucleosides or DNA with benzylating agents (40) or with phosphoramide mustard, a reactive metabolite of cyclophosphamide (41) .
Prior to this study, the role of ring-opened 7-alkylguanine adducts in carcinogenesis by alkylating agents had not been addressed. It had been suggested by numerous studies (reviewed in 1-4) that persistence of DNA lesions such as O 6 -alkylguanines which become fixed by cellular replication or misrepair results in mutagenic events initiating carcinogenesis. From this perspective, it would appear that r.o. 7-Me-G is the only persistent adduct in rat urothelial DNA after a carcinogenic initiating dose of MNU (Table II) . In preliminary studies (42), we have obtained similar data with rat kidney DNA after administration of a carcinogenic dose of N.N-dimethylnitrosamine. Sequential treatment of the rat bladder with MNU and dietary sodium saccharin, a putative bladder tumor promoter (25) (26) (27) , did not induce any alterations in the profile of urothelial carcinogen -DNA adducts derived from MNU, further supporting the premise that initiation and promotion are separate molecular events (reviewed in 43).
T he mechanism of formation of r.o. 7-Me-G in vivo is unknown, but presumably arises from 8,9-hydrolytic cleavage of 7-Me-G. However, based upon initial-sacrifice data, the relative yield of r.o. 7-Me-G from 7-Me-G appears to vary considerably from tissue to tissue, being ~ 10% in bladder DNA (Table II) , 5% in liver DNA (42) , and 20% in kidney DNA (42) . To account for these data, we hypothesize that the formation of r.o. 7-Me-G is enzyme-catalyzed and that this hydrolase has a relatively high K m for 7-Me-G in the DNA. In addition, the rate of enzymatic ring-opening of 7-Me-G could be affected by alkylation of other sites. Thus, r.o. 7-Me-G formation may occur only at high levels of DNA alkylation (>0.01%), such that significant accumulation ceases as 7-Me-G and other adduct levels are rapidly depleted (cf. Table II and reference 13). This could account for the lack of carcinogenicity of methyl methanesulfonate and dimethyl sulfate in several tissues where high levels of 7-Me-G, but not other adducts, are formed (44) . The removal of r.o. 7-Me-G could then be catalyzed by a hepatic glycosylase (24) and this may account for the loss of the ring-opened adduct from liver DNA in vivo (42) . However, this glycosylase may not be expressed in the bladder epithelium, resulting in the persistence of r.o. 7-Me-G in the carcinogen-target tissue. In this regard, Tudor et al. (45) have recently reported that methyl methanesulfonate is a weak carcinogen for the urinary bladder when given by direct instillation.
The mutagenic potential of r.o. 7-Me-G has recently been studied in an in vitro DNA replication system using E. coli DNA polymerase I and a poly(dG:dQ template containing r.o. 7-Me-G (46) . The results showed that r.o. 7-Me-G blocked chain elongation without mispairing, and it was suggested that this lesion represents a lethal event. However, in an intact cell replication system, r.o. 7-Me-G, which is now a pyrimidine might be recognized by repair enzymes as thymidine and result in a G:C to T:A transversion. It is interesting to note that such a mutation has been recently reported in E. coli for the lad gene after treatment with aflatoxin B v which alkylates the N-7 position of guanine, yielding 8,9-purine ring-opened adducts and apurinic sites (47) .
